Health officials in the U.S. and Europe have warned that patients who use the diabetes drug Actos may be in danger of developing bladder cancer. These warnings have prompted an Actos recall in France and Germany. U.S. health officials have not announced any plans to recall Actos in this country.
In June 2011, the Food and Drug Administration issued an Actos warning based on results from a 10-year study of the drug. The study found that patients who were prescribed the highest doses of the drug also faced at an increased risk of developing bladder cancer symptoms. Researchers also found that patients who use Actos for more than one year are 40% more likely to be diagnosed with bladder cancer than those not using the drug.
A July 2012 study published in the Canadian Medical Association Journal determined that some individuals with type 2 diabetes are at a 40% increased risk of developing bladder cancer prior to using any type of diabetes drug. The study included data from over 2.6 million participants and determined that the use of Actos heightened the risk of bladder cancer by 22%.
A four-year study conducted by researchers in France also uncovered a link between the long-term or high-dose use of Actos and bladder cancer. According to a press release issued by French health officials, patients in the study were 75% more likely to develop bladder cancer when taking Actos at higher doses. Patients who used the drug for more than one year also faced a significantly increased risk of receiving a bladder cancer diagnosis.
If you or a loved one took Actos and have been diagnosed with bladder cancer, you may qualify to file a lawsuit. To receive a free legal consultation to find out if you are eligible for a lawsuit, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.